Skip to main content

Published locations for Surgical outcomes favor addition of nivolumab to neoadjuvant chemo in resectable lung cancers

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Surgical outcomes favor addition of nivolumab to neoadjuvant chemo in resectable lung cancers

User login

  • Reset your password
  • /content/surgical-outcomes-favor-addition-nivolumab-neoadjuvant-chemo-resectable-lung-cancers
  • /fedprac/article/241381/lung-cancer/surgical-outcomes-favor-addition-nivolumab-neoadjuvant-chemo
  • /oncologypractice/article/241381/lung-cancer/surgical-outcomes-favor-addition-nivolumab-neoadjuvant
  • /fedprac/avaho/article/241381/lung-cancer/surgical-outcomes-favor-addition-nivolumab-neoadjuvant
  • /hematology-oncology/article/241381/lung-cancer/surgical-outcomes-favor-addition-nivolumab